Skip to the main content.
Request Demo

Helping Patients Navigate Affordability Challenges

Want to See Us in Action?

Request a demo to see how CareMetx helps patients avoid affordability roadblocks.

Request Demo

It is common for affordability barriers to present obstacles for patients trying to get started on therapies. This is often a key decision driver on whether the patient makes a decision to start on a therapy.


This is why we believe that the integration of processes to achieve patient affordability is a key component of the overall patient journey. With CareMetx’s expertise in helping both providers and patients navigate these areas, we will remove this critical barrier to care. 

That means your patients are much less likely to hit roadblocks.  
  • Integrate your Medicare eBV and Low-Income Subsidy transactions with Patient Assistance Programs processing in order to determine whether a patient is already enrolled into a Low-Income Subsidy tier. This capability allows you to identify alternative sources of funding which a patient may qualify for before enrolling the patient into Patient Assistance Programs. 
  • Streamline your Copay and Patient Assistance Programs enrollment, qualification and triage processes.
  •  Reduce dependencies on financial documentation through our income validation partnership with a leading national financial clearinghouse. 
Affordability Enablers

Copay workflows and patient enrollment

Patient Assistance Programs assessment
Patient Assistance Program

Latest Insights

3 min read
The Key to Better Patient Support: Picking an Adherence-Focused Vendor
Patient support programs have traditionally aimed to ensure that patients can access and afford their therapies....
2 min read
To Provide Accurate Medical Benefits, Site of Care Matters
For patients requiring specialty medications, the care journey can be especially challenging. The more complicated the...
3 min read
How Do Market Access Leaders View the Future of Patient Services?
Market access leaders play a crucial role in the pharmaceutical industry by ensuring that patients can access and...